Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

The Lancet ◽  
2013 ◽  
Vol 381 (9869) ◽  
pp. 825-835 ◽  
Author(s):  
Timo Vesikari ◽  
Susanna Esposito ◽  
Roman Prymula ◽  
Ellen Ypma ◽  
Igor Kohl ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document